A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008863/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics and
pharmacodynamics of the study drug dulaglutide compared to placebo in pediatric participants
with type 2 diabetes. The study duration is approximately 60 weeks.
提供机构：
Vivli
创建时间：
2023-03-24
